Ganirelix Acetate, Orgalutran (ganirelix acetate) is a protein pharmaceutical. Ganirelix acetate was first approved as Ganirelix Acetate on 1999-07-29. It is used to treat ovarian hyperstimulation syndrome in the USA. It has been approved in Europe to treat assisted reproductive techniques and ovulation induction. It is known to target gonadotropin-releasing hormone receptor.
|Indication||assisted reproductive techniques, ovarian hyperstimulation syndrome, ovulation induction|
|Drug Class||Hormone-release inhibiting peptides|